Close

Novavax to Supply 76M Doses of COVID-19 Vax to Canada

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.
Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider.

Related stories

Why Successful Innovation Starts with the Right Resources

Every business wants to be innovative, but turning a...

Körber Launches PAS-X Neo MES for Small Pharma Manufacturers

Technology company Körber has introduced a new manufacturing execution...
- Advertisement -

Novavax, Inc. has reached an agreement in principle with the Government of Canada to supply up to 76 million doses of NVX-CoV2373, Novavax’ COVID-19 vaccine.

Novavax and Canada expect to finalize an advance purchase agreement under which Novavax will supply doses of NVX-CoV2373 to Canada beginning as early as 2Q21. This purchase arrangement will be subject to licensure of the Novavax vaccine by Health Canada.

NVX-CoV2373 is currently in Phase II trials to evaluate the safety and immunogenicity in the U.S. and Australia. The program expands on the age range of the Phase I portion by including older adults 60-84 years of age as approximately 50 percent of the trial population. Secondary objectives include preliminary evaluation of efficacy. In addition, a Phase IIb clinical trial to assess efficacy began in South Africa in August.

“We are pleased to work with the Canadian government on supply of our COVID-19 vaccine, an essential step to ensure broad access of our vaccine candidate,” said Stanley C. Erck, President and Chief Executive Officer of Novavax. “We are moving forward with clinical development of NVX-CoV2373 with a strong sense of urgency in our quest to deliver a vaccine to protect the world.”

“We are pleased to announce this agreement with Novavax, which will give Canadians access to a promising COVID-19 vaccine candidate. This is an important step in our government’s efforts to secure a vaccine to keep Canadians safe and healthy, as the global pandemic evolves,” said The Honourable Anita Anand, Minister of Public Services and Procurement, Government of Canada.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Latest stories

Related stories

Why Successful Innovation Starts with the Right Resources

Every business wants to be innovative, but turning a...

Körber Launches PAS-X Neo MES for Small Pharma Manufacturers

Technology company Körber has introduced a new manufacturing execution...

How Bullying Affects Young People’s Mental Health

Bullying is sometimes brushed off as a normal part...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »